Statistics
Publications
3
Citations
81
H-Index
3
Active since
2012
Affiliations
Munich Leukemia Laboratory (Germany)(Current)
C. Haferlach is an author at Munich Leukemia Laboratory (Germany) specializing in hematology, hematologic malignancies, and myeloproliferative neoplasms.
Publications per year
2012–2016
3
3
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements
Andrew Chase, Catherine Bryant, J Score et al. · Haematologica · 2012 · 35 citations · Full text
Medicine, Hematology, Oncology +17
1–3 of 3